Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN53992566
ISRCTN53992566
Completed
Not Applicable

The study of the effect of far infrared therapy on the inflammatory markers and the haemodynamic parameters of vascular access in patients with end stage renal disease

ational Science Council (Taiwan)0 sites200 target enrollmentFebruary 21, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsStenosis of arteriovenous fistulaCirculatory SystemArteriovenous fistula

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stenosis of arteriovenous fistula
Sponsor
ational Science Council (Taiwan)
Enrollment
200
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Science Council (Taiwan)

Eligibility Criteria

Inclusion Criteria

  • •Current inclusion criteria as of 03/03/2008:
  • •HD Patients:
  • •1\. Are receiving four hours of maintenance haemodialysis (HD) therapy three times weekly for at least six months
  • •2\. Are using a AVF or AV graft as the present vascular access for more than six months, without interventions within the previous three months
  • •Both HD and non\-HD ESRD patients:
  • •1\. Are without fever or clinical signs of active infection
  • •2\. Creation of AVF with the standardised surgical procedures of venous end\-to\-arterial side anastomosis or AV graft with loop conformation by cardiovascular surgeons in our hospital in the upper extremity
  • •3\. Are between 20 and 80 years of age, both genders
  • •Previous inclusion criteria:
  • •1\. Are receiving 4 hours of maintenance haemodialysis (HD) therapy three times weekly for at least six months

Exclusion Criteria

  • •Current exclusion criteria as of 03/03/2008:
  • •Patients use Perm catheter as vascular access for haemodialysis.
  • •Previous exclusion criteria:
  • •Patients use AV graft or Perm catheter as vascular access for haemodialysis.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 4
The Interactive Effect between Genetic Background of Heme Oxygenase-1 and Far Infrared Therapy on Arteriovenous (AV) Fistula Function in Hemodialysis Patients
ACTRN12610000704099Taipei Veterans General Hospital300
Active, not recruiting
Not Applicable
Effect of far-infrared therapy on blood flow, static arteriovenous fistula pressure ratio, and dialysis adequacy in hemodialysis patients
KCT0007123Hallym University Medical Center-Hangang50
Completed
Phase 2
The impact of infrared light therapy in acupuncture points on the severity of restless leg syndrome in patients undergoing hemodialysisRestless leg syndrome.Other specified extrapyramidal and movement disorders
IRCT2016112727779N3Vice chancellor for research, Kermanshah University of Medical Sciences60
Completed
Phase 1
The effect of far-infrared therapy on improving the nerve function of the feet of diabetic dialysis patients.The nerve function of the foot needs the support of the blood circulation to function effectively. FIR is beneficial to the recovery of the nerve function of the foot, but it takes a longer time. FIR is beneficial to the recovery of foot nerve function, but it takes time.diabetic dialysis patient, foot nerve function, far infrared therapy.
TCTR20220110004/A60
Recruiting
Phase 3
Comparison of efficacy of infrared heat therapy with cryotherapy as an adjunct to meglumine antimoniate in treatment of cutaneous leishmaniasisCutaneous leishmaniasis is a skin disease caused by parasite leishmania major and leishmania tropica in Pakistan province balochistan.Cutaneous leishmaniasisB55.1
IRCT20210823052264N5Combined military hospital Quetta96